Vision

The integration of technology funding and commercial operations using a new business model

Envision ALR ("Envision") was launched in 2006 with the vision of becoming an integrated operating company in Healthcare, Energy, Water, Chemicals and Materials by capitalizing on underexploited technology in the fields of Regenerative Medicine, Nanotechnology and Industrial Biotechnology.

Envision's integrated operating model and full life-cycle funding approach distinguishes it substantially from traditional Venture Capital market, allowing it to overcome substantial structural challenges confronted by traditional VCs in the technology areas of choice.

Envision has assembled a first rate team, built a pipeline of transformative technologies and forged relationships with corporations, governments and high quality investors.

Envision has been funded by investors who have contributed $1.8m in cash, as well as a number of strategic partners and service providers who have made substantial services available to Envision on a deferred payment basis.

Envision's Model

Envision has a unique business model which seeks to draw out the complementaries of its three key sectors.

• Each area is independently and fundamentally attractive
• Competence in all three sectors spreads risk and increases long-term opportunities
• Envision's IP targetting program is value-based and source-agnostic